Iraq continues to document a sustained improve within the variety of COVID-19 instances throughout all Governorates, a rising pattern that surpassed these recorded on the similar interval in 2020. That is regarding as a result of Intensive Care Unit beds proceed filling up quicker in lots of governorates because the improve in COVID-19 instances began in early 2021, limiting entry for folks with different well being situations.
Throughout Week 14, Iraq MOH reported 43 848 new instances of COVID19 infections, up from 41 140 in Week13, representing 6.2% improve. There isn’t a important distinction within the mortality numbers in Week 14 (250) in comparison with Week 13, the place 251 folks died because of COVID-19, which could possibly be related to the continuing COVID-19 vaccinations marketing campaign countrywide.
WHO continued to assist the Ministry of Well being to construct the capability of the Expanded Programme for Immunization (EPI) focal factors and Pharmacovigilance focal factors from hospitals on monitoring and response to various kinds of Adversarial Results Following Immunization (AEFI) and Adversarial Results of Particular Curiosity (AESI within the communities.
By the tip of this reporting interval, Iraq had three forms of COVID-19 vaccines in use. These embrace AZD1222 (AstraZeneca/SKBio) shipped via the COVAX Facility, Sinopharm from China, and Pfizer/BioNTech.